Search Results 1-10 of 16337 for Cystinosis+agents

  1. Cysteamine (oral route) - Side effects & dosage - Mayo Clinic

    Cysteamine is used to prevent damage that may be caused by the buildup of cystine crystals in organs such as the kidneys (nephropathic cystinosis). Cystinosis ...

  2. Cysteamine (ophthalmic route) - Mayo Clinic

    Cysteamine eye drops is used to treat cystine crystal buildup in the cornea (front part of the eye) of patients with cystinosis. Cystinosis is a hereditary ...

  3. Exploring Mechanisms Of Action And Resistance Of Therapeutic Agents In Patients With B-cell Malignancies - Mayo Clinic

    Clinical Trials · Exploring Mechanisms Of Action And Resistance Of Therapeutic Agents In Patients With B-cell Malignancies · More about research at Mayo Clinic.

  4. Central-acting agents - Mayo Clinic

    When central-acting agents are used · Attention-deficit/hyperactivity disorder (ADHD). · Medicine withdrawal, such as from opioid pain medicines. · Hot flashes in ...

  5. Cytotoxic Action of Novel Anti-Neoplastic Agents - Anticancer Drug Action Laboratory - Mayo Clinic Research

    Dr. Kaufmann and his team in the Anticancer Drug Action Lab at Mayo Clinic are studying the cytotoxic action of novel anti-neoplastic agents.

  6. A Study to Evaluate the Patterns of Use of Biological Agents and Risk Factors for Discontinuation of Agents in Pediatric Crohn’s Disease (CD) and Ulcerative Colitis (UC) within the Pediatric Population - Mayo Clinic

    ... Agents in Pediatric Crohn's Disease (CD) and Ulcerative Colitis (UC) within ... Documentation of date of initiation of each biological agent and date of ...

  7. Analyses of Metabolic Agents Following Brain Radiation - Mayo Clinic

    The purpose of this study is to determine the feasibility of serial cerebrospinal fluid (CSF) assessments to evaluate the pharmacodynamic impact of agents ...

  8. A Study to Evaluate Agents to Treat Moderately or Severely Ill Patients with Severe Acute Respiratory Syndrome Coronavirus 2 - Mayo Clinic

    This study aims to evaluate each agent with respect to speed of recovery, mortality, illness severity, and hospital resource utilization. Each agent will be ...

  9. Study of XL092 in Combination With Immuno-Oncology Agents in Subjects With Solid Tumors - Mayo Clinic

    About this study. The purpose of this study is to evaluate the safety tolerability, PK, preliminary antitumor activity, and effect of biomarkers of XL092 ...

  10. Metabolic Agents Pharmacodynamic Analyses After Brain Radiation - Mayo Clinic

    About this study. Magnetic resonance spectroscopy is a feasible technique within brain tumor patients to detect metabolic differences between tumor and ...